01258nas a2200157   4500000000100000008004100001260001200042100001400054700001300068245013800081856007600219300001400295490000700309520077000316022001401086       2024                            d  c11/20241 aBijlwan A1 aPandey P00aThe national action plan for prevention and control of snakebite envenoming in India (NAPSE): Its role, opportunities and challenges.  uhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11668436/pdf/JFMPC-13-5438.pdf  a5438-54390 v133 a<p>The National Action Plan for Prevention and Control of Snakebite Envenoming in India (NAPSE), launched in March 2024, is a crucial and timely initiative aimed at addressing one of the country’s most persistent public health challenges. Snakebites in India are responsible for nearly 50% of global snakebite deaths, with an estimated 50,000 fatalities annually out of 3–4 million snakebite cases.[<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11668436/#R1">1</a>] The goal of NAPSE is to halve snakebite-related deaths and disabilities by 2030 through a comprehensive and multifaceted approach. This editorial delves into the key features, strategies, and implications of NAPSE, highlighting its potential to transform snakebite management in India.</p>
  a2249-4863